Axon Drugs Private Limited

Pharmaceutical company manufacturing and exporting various drugs, supplying to government institutions. WHO-GMP certified.

1990 | Tiruvallur, Tamil Nadu (India) | Active
Last Updated:

Axon Drugs Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 34 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 14.21 Cr
  • Satisfied Charges ₹ 5.69 M
  • Revenue Growth 3.71%
  • Profit Growth 91.12%
  • Ebitda 46.88%
  • Net Worth 16.24%
  • Total Assets 9.10%

About Axon Drugs

Axon Drugs Private Limited (ADPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 July 1990 and has a history of 34 years and ten months. Its registered office is in Tiruvallur, Tamil Nadu, India.

The Corporate was formerly known as Alsalabs Pvt Ltd. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr.

The company currently has active open charges totaling ₹14.21 Cr. The company has closed loans amounting to ₹5.69 M, as per Ministry of Corporate Affairs (MCA) records.

Damodaram Harirajan, Pushpakala Harirajan, and Vikram Harirajan serve as directors at the Company.

Company Details

  • Location

    Tiruvallur, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24117TN1990PTC019380

  • Company No.

    019380

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    10 Jul 1990

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Pharma
Company report

Axon Drugs Private Limited

Explore comprehensive data for Axon Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Axon Drugs?

Executive Team (1)

NameDesignationAppointment DateStatus
Damodaram Harirajan Country flag representing In Managing Director10-Jul-1990Current

Board Members (2)

NameDesignationAppointment DateStatus
Vikram Harirajan Country flag representing In Director 14-Aug-2008Current
Pushpakala Harirajan Country flag representing In Whole-Time Director 10-Jul-1990Current

Financial Performance of Axon Drugs.

Axon Drugs Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.71% increase. The company also saw a substantial improvement in profitability, with a 91.12% increase in profit. The company's net worth Soared by an impressive increase of 16.24%.

Axon Drugs revenue growth over time
Axon Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
3.71%
Revenue from Operations
4.20%
Total Assets
9.10%
Profit or Loss
91.12%
Net Worth
16.24%
EBITDA
46.88%

What is the Ownership and Shareholding Structure of Axon Drugs?

In 2024, Axon Drugs had a public holding of 8.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹14.21 Cr

Satisfied Charges

₹0.57 Cr

Charges Breakdown by Lending Institutions

  • Indian Overseas Bank : 14.09 Cr
  • Indian Overaseas Bank : 0.12 Cr

Latest Charge Details

DateLenderAmountStatus
22 Jul 2013Indian Overseas Bank₹10.00 CrOpen
28 Feb 2000Indian Overseas Bank₹4.30 MOpen
07 Oct 1999Indian Overseas Bank₹0.40 MOpen
21 Mar 1997Indian Overseas Bank₹0.50 MOpen
24 Jul 1992Indian Overaseas Bank₹0.70 MOpen

How Many Employees Work at Axon Drugs?

Axon Drugs has a workforce of 53 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Axon Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axon Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Axon Drugs

Recent activity within the organization

  • Annual General Meeting

    Axon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Axon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

  • Charges

    A charge with Indian Overseas Bank of Rs. 3.57 Cr registered on 18 Jul 1992 with Charge ID 90290048 was modified on 12 Jan 2024.

  • Charges

    A charge with Indian Overseas Bank amounted to Rs. 10.00 Cr with Charge ID 10439382 was registered on 22 Jul 2013.

  • Director Appointment

    Vikram Harirajan was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 16 years 9 months .

  • Charges

    A charge registered on 26 Jul 2002 via Charge ID 90301095 with Tamil Nadu Industrial Investment Corporation Limited was fully satisfied on 28 Aug 2007.

Frequently asked questions

  • What is the Incorporation or founding date of Axon Drugs Private Limited?

    Axon Drugs Private Limited was incorporated on 10 Jul 1990.

  • What is authorized share capital and paid-up capital of Axon Drugs Private Limited?

    The authorized share capital of Axon Drugs Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.00 Cr.

  • Who are the current board members & directors of Axon Drugs Private Limited?

    Currently 3 directors are associated with Axon Drugs Private Limited.

    • Damodaram Harirajan
    • Pushpakala Harirajan
    • Vikram Harirajan
  • What is the registered address of Axon Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Axon Drugs Private Limited is Plot No.14 Santhosh Nagar, Korattur North India, Chennai, Tamil Nadu, 600076.

  • What is the corporate identification number (CIN) and company number of Axon Drugs Private Limited?

    The corporate identification number (CIN) of Axon Drugs Private Limited is U24117TN1990PTC019380 and the company number is 019380 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Axon Drugs Private Limited?

    The Official website of Axon Drugs Private Limited is https://www.axondrugs.com

  • What has been the recent revenue trend for Axon Drugs Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Axon Drugs Private Limited has risen by 3.71%.

  • How many employees does Axon Drugs Private Limited currently have?

    As Per 2024 financial reports, 53 employees are currently employed by Axon Drugs Private Limited.

  • What change has been observed in the net worth of Axon Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Axon Drugs Private Limited has experienced an upsurge of 16.24%.

  • What are the total open charges for Axon Drugs Private Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Axon Drugs Private Limited amount to ₹ 14.21 Cr.

  • When was the last Balance Sheet of Axon Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Axon Drugs Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development